Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Histogen Inc | HSTO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.658 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.658 | 0.658 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.3596 - 1.05 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.658 | USD |
Histogen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 2.81M | - | - | - | -0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Histogen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/18/2024 | 16:29 | GlobeNewswire Inc. | Histogen Files for Voluntary Chapter 11 Protection to.. |
| 1/04/2024 | 12:21 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section.. |
| 12/14/2023 | 15:15 | GlobeNewswire Inc. | Histogen Announces Second Adjournment of Special Meeting of.. |
| 12/05/2023 | 15:05 | GlobeNewswire Inc. | Histogen Announces Adjournment of Special Meeting of.. |
| 11/16/2023 | 15:07 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 10/18/2023 | 15:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 10/04/2023 | 15:08 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 10/03/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/26/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/18/2023 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/18/2023 | 15:05 | GlobeNewswire Inc. | Histogen Announces Board Approval of Complete Liquidation.. |
| 8/15/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSTO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.83 | 1.05 | 0.3596 | 0.6022345 | 171,183 | -0.172 | -20.72% |
| 3 Years | 22.60 | 24.60 | 0.3596 | 8.45 | 900,032 | -21.94 | -97.09% |
| 5 Years | 88.20 | 100.00 | 0.3596 | 15.09 | 1,029,029 | -87.54 | -99.25% |
Histogen Description
| Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop. |
